ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2025
Sex-Based Differences in the Association of Epigenetic Age Acceleration with Alzheimer's Disease Biomarkers and Cognitive Measures.
Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Alzheimer's Disease (AD) is a neurodegenerative disorder marked by cognitive and functional decline. Biological sex has been linked to differences in lifetime AD risk, AD-related neuropathology, and the rate of cognitive decline, although the underlying biological mechanisms driving these disparities remain unclear. Epigenetic Age Acceleration-a metric derived from epigenetic aging clocks-has been associated with numerous aging-related conditions such as AD. Although there is promise in using Epigenetic age acceleration as a biomarker for several aging related diseases, the underlying mechanism that aging clocks are actually predicting is not well understood. In this study, we used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to examine how sex influences the relationship between age acceleration and cognitive performance as well as brain volume. Our findings suggest that, although epigenetic age acceleration can predict changes in brain structure, these changes don't appear to be different across sexes. Future research should focus on validating these findings in an external cohort and exploring them longitudinally.
Identifiers
40502223PMC12150745What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.